undamentalytics Newsletter
Sign in

Shattuck Labs, Inc. balance sheet

At the end of fiscal 2025, Shattuck Labs, Inc. had total assets of $91.0m, total liabilities of $8.6m and shareholders' equity of $82.4m. It held $54.2m in cash against $0 of debt: net cash of $54.2m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents71589247126575463
Total current assets423462881851437982213
Total assets453492992051609191221
Accounts payable321072224
Deferred revenue (current)138000———
Total current liabilities2017252511978
Total debt00000000
Total liabilities303927291511910
Shareholders' equity−353102721761458082211
Non-controlling interests and other (assets − liabilities − equity)49———————
Net debt (negative = net cash)−7−158−92−47−126−57−54−63
Shares outstanding15m—42m42m47m48m63m101m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: MNOV vs STTKLGVN vs STTKDARE vs STTK

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Shattuck Labs, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Shattuck Labs, Inc.